Barrier laser photocoagulation for recurrent retinal detachment

被引:0
作者
Cheema, Rizwan A. [1 ]
Gandhewar, Ravi [1 ]
Kehdi, Elias [1 ]
机构
[1] Univ Wales Hosp, Vitreo Retinal Serv, Cardiff Eye Unit, Cardiff CF14 4XW, S Glam, Wales
关键词
recurrent retinal detachment; proliferative vitreoretinopathy (PVR); laser photocoagutation; barrier laser photocoagulation; demarcation laser photocogulation;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe results of barrier laser photocoagutation in preventing progression of recurrent retinal detachment. Methodology: Prospective review of five patients with recurrent retina[ detachment confined to the peripheral inferior retina. Three rows of barrier argon laser photocoagutation of moderate intensity white burns were performed. Patients were observed carefully after laser photocoagulation for signs of progression of retinal detachment beyond the barrier laser confines. Results: Barrier laser photocoagutation was successful in limiting the progression of retinal detachment in all cases during follow-up period (average 34.4 months), and maintaining good central visual acuity. Conclusion: Barrier laser photocoagulation can be useful in preventing progression of recurrent retinal detachment in selected patients.
引用
收藏
页码:941 / 945
页数:5
相关论文
共 43 条
  • [41] Effect of Macular Internal Limiting Membrane Peeling on Single Surgery Success Rates of Vitrectomy for Uncomplicated, Primary Macula-Off Retinal Detachment
    Martens, Rosanna K.
    Chen, Chao
    Ehmann, David S.
    Greve, Mark
    Seamone, Mark E.
    JOURNAL OF VITREORETINAL DISEASES, 2023, 7 (03) : 193 - 198
  • [42] Efficacy of 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) in high-risk pediatric retinal detachment; randomized clinical trial
    Mohamed Nasr
    Ahmed Abdelhadi
    Amr Bessa
    Tamer Moussa Ibrahim
    BMC Ophthalmology, 24
  • [43] Efficacy of 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) in high-risk pediatric retinal detachment; randomized clinical trial
    Nasr, Mohamed
    Abdelhadi, Ahmed
    Bessa, Amr
    Ibrahim, Tamer Moussa
    BMC OPHTHALMOLOGY, 2024, 24 (01)